Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Granada – page 15

395 clinical trials in Granada, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Granada at a glance
395
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

395 trials in Granada

Open in trial search

Neoplasm malignant

Not yet recruiting

Study on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Sutro Biopharma Inc.

Ulcerative keratitis

Not yet recruiting

Study on the Effectiveness of NANOULCOR for Patients with Severe Corneal Ulcers Using Allogenic Limbal Cells and Keratocytes

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogenic Corneal-Derived Adult Keratocytes, Ex-Vivo Expanded
  • Sponsor:Fundacion Publica Para La Investigacion Biosanitaria De Andalucia Oriental Alejandro Otero

Cleft lip and palate

Not yet recruiting

Study on the Safety and Feasibility of Using Autologous Oral Mucosa-Derived Keratinocytes and Fibroblasts for Treating Cleft Palate Patients

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Autologous Oral Mucosa-Derived Adult Fibroblasts, Ex-Vivo Expanded
  • Sponsor:Fundacion Publica Para La Investigacion Biosanitaria De Andalucia Oriental Alejandro Otero

Pancreatitis acute

Not yet recruiting

Study Comparing Sodium Chloride and Lactated Ringer's Solution for Patients with Acute Pancreatitis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Potassium Chloride
  • Sponsor:Hospital General Universitario Dr. Balmis

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Transitional cell carcinoma

Not yet recruiting

Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:European Uro-Oncology Group Stichting

Hypertension

Not recruiting

Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lorundrostat
  • Sponsor:Mineralys Therapeutics Inc.

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Hidradenitis

Not recruiting

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Dermatitis atopic

Not recruiting

Study of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Hidradenitis

Not recruiting

Study on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Granada

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on multiple cancer types including colorectal cancer, breast cancer, and glioblastoma. Studies are evaluating novel treatment approaches and combination therapies.

  • Metastatic colorectal cancer treatment optimization
  • Triple-negative breast cancer therapies
  • Prostate cancer diagnostics and treatment

Advanced imaging techniques and targeted therapies are being investigated to improve patient outcomes.

02 Respiratory Medicine

Research targeting respiratory conditions with a focus on chronic obstructive pulmonary disease. Studies are examining new therapeutic approaches for moderate to severe cases.

  • COPD exacerbation management
  • Novel therapeutic antibodies
  • Bronchial disease treatments

Emphasis on reducing disease progression and improving quality of life for patients.

03 Dermatology Studies

Clinical investigations in various skin conditions including plaque psoriasis and atopic dermatitis. Research focuses on innovative biological treatments.

  • Moderate to severe psoriasis therapies
  • Hidradenitis suppurativa treatments
  • Novel dermatological interventions

Trials aim to develop more effective treatments for chronic skin conditions.

04 Neurological Research

Studies investigating treatments for Alzheimer's disease in specific populations, particularly focusing on prevention and management of associated conditions.

  • Alzheimer's disease in Down syndrome
  • Seizure prevention strategies
  • Neurological disorder management

Research aims to improve quality of life for patients with complex neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.